ALA 2.78% 18.5¢ arovella therapeutics limited

Has Suda turned the corner!, page-24

  1. 1,261 Posts.
    lightbulb Created with Sketch. 197
    Yup, where's the evidence Steve? The clinical, pre-clinical evidence that your delivery system does what you claim it does? Until there is more than p1ss and wind from you on this key point, what partnerships can you reasonably expect to get over the line?
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.